US drug pricing changes raise concerns over medicine access in Europe
Donald Trump’s “most favored nation” strategy for the U.S. could force up prices in Europe — and make medicines scarcer.
UCB increases profit forecasts after strong performance in first half of 2025
UCB Reports 25% Revenue Growth in First Half of 2025 Belgian pharmaceutical group UCB announced a 25% increase in turnover to 3.49 billion euros for the first half of 2025, prompting the
Lithuania seeks NATO assistance to enhance air defenses following second drone incursion
Plans to Renegotiate Pharmaceutical Regulations Amid EU-US Trade Tensions Amid escalating trade tensions with the United States, the European Union’s efforts to enhance its competitiveness are prompting a reconsideration of proposed pharmaceutical
EU countries and MEPs urge Commission to preserve equal treatment at work bill
EU to Revise Pharmaceutical Legislation Amid Trade Tensions with the U.S. As the European Union intensifies its efforts to enhance competitiveness in the face of escalating trade tensions with the United States,